The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions.
Creator
Regenberg, Alan
Mathews, Debra J.H.
Blass, David M.
Bok, Hilary
Coyle, Joseph T.
Duggan, Patrick
Faden, Ruth
Finkel, Julia
Gearhart, John D.
Hillis, Argye
Hoke, Ahmet
Johnson, Richard
Johnston, Michael
Kahn, Jeffrey
Kerr, Douglas
King, Patri
Bibliographic Citation
Journal of Cerebral Blood Flow and Metabolism 2009 January; 29(1): 1-9
Permanent Link
http://hdl.handle.net/10822/514093External Link
Full Text from PublisherDate
2009-01Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges
Duggan, P. S.; Siegel, A. W.; Blass, David M.; Bok, Hilary; Coyle, J. T.; Faden, R.; Finkel, J.; Gearhart, J. D.; Greely, H. T.; Hillis, A.; Hoke, A.; Johnson, R.; Johnston, M.; Kahn, J.; Kerr, D.; King, P.; Kurtzberg, J.; Liao, S. M.; McDonald, J. W.; McKhann, G. (2009-05)The prospect of using cell-based interventions (CBIs) to treat neurological conditions raises several important ethical and policy questions. In this target article, we focus on issues related to the unique constellation ...